Related Experiment Video
Updated: Jun 25, 2026
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
Published on: February 1, 2020
The Role of Circulating Tumor DNA in Surgical Management of Pancreatic Cancer: Systematic Review and Meta-analysis
Filipe C Borges1,2, Mafalda S Pinto2, Miguel F Borges1,2
1Department of Surgical Oncology, Hepato-Pancreato-Biliary Surgery Unit, Champalimaud Foundation, Lisbon, Portugal.
Summary Of Background Data:
PDAC is the fifth leading cause of cancer-related death in Europe. Surgery is the only possible cure; however, recurrence is common.
Objective:
This systematic review and meta-analysis aimed to assess the value of circulating tumor DNA (ctDNA) in pre- and post-surgery liquid biopsies as a prognostic biomarker for recurrence and survival in patients with PDAC.
Methods:
We performed a systematic review and meta-analysis of studies identified in Medline (via PubMed) and Web of Science. The primary outcomes were disease-free survival (DFS) and overall survival (OS).
Results:
18 studies (965 patients) were included in the analysis. The presence of preoperative ctDNA was significantly associated with lower DFS (HR: 2.08; 95% CI: 1.63-2.65; P<0.00001) and OS (HR: 2.31; 95% CI: 1.66-3.22; P<0.00001). Postoperative ctDNA positivity was correlated with lower DFS (HR: 3.29; 95% CI: 2.10-5.15; P<0.00001) and OS (HR: 3.42; 95% CI: 2.06-5.67; P<0.00001). In a subgroup analysis, ctDNA presence was also significantly associated with worse OS in both upfront resection (HR: 2.04, 95% CI: 1.14-3.66; P=0.02) and neoadjuvant treatment (HR: 2.35; 95% CI: [1.56-3.54]; P<0.00001) subgroups.
Conclusion:
Both preoperative and postoperative ctDNA are significant negative prognostic markers in patients with PDAC undergoing surgery. In subgroup analysis, ctDNA maintained its prognostic value in both the upfront resection and neoadjuvant treatment groups. Monitoring ctDNA can help personalize treatment, specifically in the selection of patients for neoadjuvant, surgical, and adjuvant therapies.
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...